© 1989 British Society for Rheumatology
case-report |
A SERIAL STUDY OF ANTICARDIOLIPIN ANTIBODY AND ANTIMITOCHONDRIAL ANTIBODY TYPE M5 IN A PATIENT WITH POLYARTHRITIS AND POLYMYOSITIS

*Department of Rheumatology, Mater Misericordiae Hospital Dublin 7, Eire
Department of Immunology, Mater Misericordiae Hospital Dublin 7, Eire
Correspondence to:
Correspondence to Dr. C. Barry.
A 22-year-old female presented with polyarthritis and subsequent polymyositis. Initially, she had moderately high levels of anticardiolipin (aCl) and antimitochondrial antibody (AMA) type M5. Following corticosteroid therapy, the anticardiolipin antibody rapidly fell to background levels but reappeared with the onset of two significant clinical events.
KEY WORDS: Anticardiolipin antibody, Antimitochondrial antibody, Polymyositis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Andrejevic, B. Bonaci-Nikolic, M. Sefik-Bukilica, and R. Petrovic Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies Lupus, October 1, 2007; 16(10): 788 - 793. [Abstract] [PDF] |
||||
![]() |
A. Lynch, J. Rutledge, J. Stephens, J. Murphy, R. Marlar, G. Davila, M. Santos, and W. Emlen Longitudinal measurement of anticardiolipin antibodies during normal pregnancy: a prospective study Lupus, October 1, 1995; 4(5): 365 - 369. [Abstract] [PDF] |
||||
